|
01 Jun 2007 |
Top line results of phase III study in acute ischemic stroke (DIAS-2) do not demonstrate difference between desmoteplase and placebo
|
|
26 May 2007 |
Mircera receives positive opinion in Europe for the treatment of anaemia due to chronic kidney disease
|
|
26 May 2007 |
Tercica Reports Increlex Receives CHMP Positive Opinion for the Treatment of Severe Primary IGF-1 Deficiency
|
|
25 May 2007 |
Emisphere Announces Initiation of Phase III Clinical Program of Oral Calcitonin for the Treatment of Osteoarthritis
|
|
24 May 2007 |
Ozarelix Phase 2 Data in Benign Prostatic Hypertrophy Presented at Annual Meeting of American Urological Association
|
|
24 May 2007 |
Northfield Laboratories Reports Results of Pivotal Phase III Trauma Study
|
|
23 May 2007 |
Scil Technology GmbH obtained Competent Authority Approval for Phase II Periodontitis Study
|
|
23 May 2007 |
Phase 1b insulin clinical trial commenced
|
|
23 May 2007 |
Voraxaze (TM) Update
|
|
22 May 2007 |
Roche receives approvable letter for Mircera in the United States
|
|
22 May 2007 |
Intarcia Therapeutics Announces Presentation of Final Results from a Phase 2 Combination Study for the Treatment of Hepatitis C at the Digestive Disease Week Conference
|
|
19 May 2007 |
Curis Provides Update on BMP-7 Program
|
|
16 May 2007 |
Phylogica Generates Multiple Drug Candidates For Treatment Of Rheumatoid Arthritis
|
|
16 May 2007 |
OMRIX Biopharmaceuticals Receives Food and Drug Administration (FDA) Approval for Liquid Fibrin Sealant, Evicel(TM), For Use in Vascular Surgery
|
|
15 May 2007 |
Dyax Corp. Treats First Patient in Phase 2 Trial for On-Pump Cardiothoracic Surgery
|
|
15 May 2007 |
Actilyse(R) (alteplase) recommended by National Institute for Health and Clinical Excellence for treatment of acute ischaemic stroke
|
|
15 May 2007 |
Acceleron Pharma's ACE-031 Increases Muscle Mass and Strength in Preclinical Studies
|
|
15 May 2007 |
Nautilus Biotech receives FDA approval for Phase 1 clinical trial in the USA for oral Belerofon(R), its long-lasting, Interferon-alpha drug
|
|
11 May 2007 |
Viropro Inc. and Intas Biopharmaceuticals Announce the Signature of a Binding MOU for the Development and Production of a Therapeutic Protein
|
|
10 May 2007 |
FDA Advisory Committee Reviews Data on IDM Pharma's Junovan(TM) (mifamurtide) for Treatment of Osteosarcoma
|
|
10 May 2007 |
Altus Pharmaceuticals Initiates Phase III Clinical Trials of ALTU-135 for Cystic Fibrosis Patients with Pancreatic Insufficiency
|
|
09 May 2007 |
Oramed Pharmaceuticals Begins Phase 1 Human Clinical Trials
|
|
09 May 2007 |
AEterna Zentaris Regains Exclusive Worldwide (ex-Japan) Rights from Solvay for Cetrorelix in Endometriosis Indication
|
|
09 May 2007 |
Multiferon(R) Shows Potent Activity in Preventing the Progression of Malignant Melanoma; Study to be Published
|
|
08 May 2007 |
Pacgen Announces Positive Results from Phase I/II Trial of Novel Anti-Fungal Drug
|
